RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
Clinical trials for RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets rare gene mutation in Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-stage trial tests an oral drug called AG-120 in people with advanced blood cancers, like acute myeloid leukemia, that have a specific IDH1 mutation. The study aims to find the safest dose and see if the drug can control the disease. About 291 participants will take the…
Matched conditions: RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE1 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for elderly blood cancer patients: experimental transplant prep shows promise
Disease control Recruiting nowThis study tests a new combination of drugs (cladribine, lisaftoclax, busulfan, and others) given before a stem cell transplant in 30 older adults (age 50+) with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes. The goal is to see if this approach can re…
Matched conditions: RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for tough AML: targeted pill plus chemo combo tested
Disease control Recruiting nowThis study tests whether adding the targeted drug venetoclax to a standard chemotherapy regimen (CLAG-M) can improve outcomes for adults with relapsed or refractory acute myeloid leukemia (AML). About 52 participants will be randomly assigned to receive either CLAG-M alone or CLA…
Matched conditions: RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC